24/04/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

24/04/2025

Apr 24, 2025, 12:42 | Blog
Hussein Alshamali: The Second General Meeting of the WHO Global Coordination Mechanism on NCDs has commenced
Hussein Alshamali, Technical Officer NCDs at World Health Organization, shared a post on LinkedIn: "The Second…
Apr 24, 2025, 12:33 | Blog
The HOPE Summit is 10 days away - LUNGevity Foundation
LUNGevity Foundation shared a post on LinkedIn: "The HOPE Summit is 10 days away! It is…
Apr 24, 2025, 12:22 | Blog
EORTC Quality of Life Group shares new framework for patient-reported outcome measurement
EORTC - European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:…
Apr 24, 2025, 12:10 | Science
Joshua Brody: Quick summary on using CRISPR to edit T-cells
Joshua Brody, Director of Lymphoma Immunotherapy Program and Associate Professor of Division of Hematology and…
Apr 24, 2025, 11:59 | Blog
Mahmoud Hammad: The International Childhood Conference 5th Edition
Mahmoud Hammad, Consultant Pediatric Hematology/Oncology and Stem Cell Transplant at Saudi German Hospital Egypt, shared…
Apr 24, 2025, 11:44 | Blog
ESO College announces Partial Scholarship of Excellence for Molecular Oncology Master Program
European School of Oncology (ESO) shared a post on LinkedIn: "ESO College is very pleased…
Apr 24, 2025, 11:39 | Blog
Kevin Conroy: I’m thrilled to announce the launch of Oncodetect by Exact Sciences
Kevin Conroy, Chairman and CEO at Exact Sciences, shared a post on LinkedIn: "At Exact Sciences,…
Apr 24, 2025, 11:31 | Blog
The CancerX collaboration proposal deadline has been extended to April 26th
CancerX shared a post on LinkedIn: "Deadline extended! Last chance for cancer innovators. Don't miss…
Apr 24, 2025, 11:19 | Blog
Bichoy Gabra: An illustration of the genes and pathways associated with targeted drugs for NSCLC
Bichoy Gabra, Oncology Infusion Pharmacy Services Manager at Moffitt Cancer Center, shared a post on LinkedIn:…
Apr 24, 2025, 11:06 | Blog
New dosing options for PD-1 inhibitor in first and second-line esophageal squamous cell carcinoma - BeOne Medicines
BeOne Medicines shared a post on LinkedIn: "The FDA has approved new dosing options for our…
All: 78 Posts: 41 - 50
Special Coverage